The resources on this page are offered by Bristol Myers Squibb to assist healthcare providers in caring for patients and conducting research with BMS medicines.
Welcome to Bristol Myers Squibb’s
Medical resources for healthcare providers
The Medical Division at Bristol Myers Squibb communicates the safe and appropriate use of its medicines.
What is the Medical Division of Bristol Myers Squibb?Clinical and scientific information on BMS medicines
| EMPLICITI® (elotuzumab)> |
| INREBIC® ▼(fedratinib dihydrochloride monohydrate) > |
| REVLIMID® ▼(lenalidomide) > |
| SPRYCEL® (dasatinib)> |
| VIDAZA® (azacitidine) > |
| KENALOG® (triamcinolone acetonide) > |
| NULOJIX® (belatacept)> |
| ORENCIA® (abatacept)> |
| SOTYKTU® ▼(deucravacitinib) > |
| ZEPOSIA® ▼(ozanimod) > |
Clinical and patient resources
Find my Medical Science Liaison (MSL)
Identify the appropriate Medical Science Liaison in your area
Find a clinical trial
Explore clinical trials to enrol your patient in
Patient support and education
Support and educational resources for helping your patients access, pay for, and use our medicines
Report adverse events
Telephone: 0800 731 1736
Email: medical.information@bms.com
Haven’t found your answer yet?
Submit a question for email replyCall our UK Medical Information Center for Healthcare providers
0800 731 1736
